• About us
• Contact

Advertisement

Organisation › Details

EQT (Wallenberg family) (Group)

EQT is a leading alternative investments firm with approximately EUR 37 billion in raised capital across 24 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. EQT is an active investor and owner in the healthcare sector, including recent investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima Corporate. *

 

	Start	1994-01-01 established
	Industry	private equity
	Street	3 Hovslagargatan
	City	11148 Stockholm
	Tel	+46-8-506-55300
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	41,000,000,000 (assets, managed (2021) 2021-05-31)
		* Document for »About Section«:
		Record changed: 2024-05-05

Advertisement

More documents for EQT (Wallenberg family) (Group)

• [1] EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million"....
• [2] Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich....
• [3] EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences"....
• [4] EQT AB. (11/10/21). "Press Release: EQT Strengthens Position in Healthcare Investments by Joining Forces with LSP"....
• [5] Life Sciences Partners (LSP). (11/4/21). "Press Release: LSP Raises Record $1 Billion for Its 7th Flagship Life Sciences Fund". Amsterdam....
• [6] Egle Therapeutics SAS. (10/22/21). "Press Release: Egle Therapeutics Raises 40 million € Series A to Develop First-In-Class T-regulatory Cells Therapies Based on Treg-starvers". Paris....
• [7] Life Sciences Partners (LSP). (1/12/21). "Press Release: LSP and Philip Scheltens Launch New, Unique Fund to Fight Dementia". Amsterdam....
• [8] Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden....
• [9] Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA....
• [10] iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.